Furthermore, an epithelial–mesenchymal transition cluster analysis of NSCLC revealed that a cluster with lower expression of SP-G was associated with elevated immune checkpoints and poorer prognosis [15]. Here, SFTA2 is linked to non-small cell lung carcinoma.